WST West Pharmaceutical Services Inc

Price (delayed)

$381.07

Market cap

$28.13B

P/E Ratio

66.62

Dividend/share

$0.68

EPS

$5.72

Enterprise value

$27.97B

Highlights
The net income has soared by 62% YoY and by 22% from the previous quarter
WST's EPS has surged by 62% year-on-year and by 22% since the previous quarter
The stock's price to earnings (P/E) is 44% more than its 5-year quarterly average of 46.2 and 14% more than its last 4 quarters average of 58.3

Key stats

What are the main financial stats of WST
Market
Shares outstanding
73.82M
Market cap
$28.13B
Enterprise value
$27.97B
Valuations
Price to earnings (P/E)
66.62
Price to book (P/B)
15.44
Price to sales (P/S)
12.11
EV/EBIT
54.06
EV/EBITDA
44.42
EV/Sales
12.02
Earnings
Revenue
$2.33B
EBIT
$517.4M
EBITDA
$629.6M
Free cash flow
$307.1M
Per share
EPS
$5.72
Free cash flow per share
$4.16
Book value per share
$24.68
Revenue per share
$31.48
TBVPS
$35.2
Balance sheet
Total assets
$2.74B
Total liabilities
$910.7M
Debt
$321.4M
Equity
$1.83B
Working capital
$844.2M
Liquidity
Debt to equity
0.18
Current ratio
2.75
Quick ratio
1.97
Net debt/EBITDA
-0.26
Margins
EBITDA margin
27.1%
Gross margin
37.5%
Net margin
18.2%
Operating margin
21.3%
Efficiency
Return on assets
16.1%
Return on equity
24.1%
Return on invested capital
28.1%
Return on capital employed
22.9%
Return on sales
22.2%
Dividend
Dividend yield
0.18%
DPS
$0.68
Payout ratio
11.9%

WST stock price

How has the West Pharmaceutical Services stock price performed over time
Intraday
1.9%
1 week
1.98%
1 month
6.24%
1 year
45.41%
YTD
34.51%
QTD
6.12%

Financial performance

How have West Pharmaceutical Services's revenue and profit performed over time
Revenue
$2.33B
Gross profit
$872.7M
Operating income
$494.5M
Net income
$423.1M
Gross margin
37.5%
Net margin
18.2%
The net income has soared by 62% YoY and by 22% from the previous quarter
WST's operating income has soared by 58% YoY and by 22% from the previous quarter
The gross profit has grown by 39% YoY and by 14% from the previous quarter
WST's net margin is up by 32% year-on-year and by 13% since the previous quarter

Growth

What is West Pharmaceutical Services's growth rate over time

Valuation

What is West Pharmaceutical Services stock price valuation
P/E
66.62
P/B
15.44
P/S
12.11
EV/EBIT
54.06
EV/EBITDA
44.42
EV/Sales
12.02
WST's EPS has surged by 62% year-on-year and by 22% since the previous quarter
The stock's price to earnings (P/E) is 44% more than its 5-year quarterly average of 46.2 and 14% more than its last 4 quarters average of 58.3
The price to book (P/B) is 121% higher than the 5-year quarterly average of 7.0 and 38% higher than the last 4 quarters average of 11.2
WST's equity is up by 23% year-on-year
The P/S is 112% above the 5-year quarterly average of 5.7 and 30% above the last 4 quarters average of 9.3
West Pharmaceutical Services's revenue has increased by 23% YoY and by 8% from the previous quarter

Efficiency

How efficient is West Pharmaceutical Services business performance
WST's return on invested capital is up by 44% year-on-year and by 18% since the previous quarter
West Pharmaceutical Services's ROE has increased by 39% YoY and by 16% from the previous quarter
The company's return on assets rose by 38% YoY and by 17% QoQ
WST's return on sales is up by 28% year-on-year and by 12% since the previous quarter

Dividends

What is WST's dividend history
DPS
$0.68
Dividend yield
0.18%
Payout ratio
11.9%
Recent dividends

Financial health

How did West Pharmaceutical Services financials performed over time
WST's total assets is up by 22% year-on-year
The total liabilities has increased by 20% year-on-year but it has declined by 3% since the previous quarter
WST's debt is 82% smaller than its equity
WST's equity is up by 23% year-on-year
The debt to equity has contracted by 18% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.